DocSym
β
Searchsearch
Search
(L12.0) Bullous pemphigoid
More details coming soon
231 237 in individuals diagnosis bullous pemphigoid confirmed
8 706 deaths with diagnosis bullous pemphigoid
4% mortality rate associated with the disease bullous pemphigoid
Diagnosis bullous pemphigoid is diagnosed Women are 18.79% more likely than Men
93 894
Men receive the diagnosis bullous pemphigoid
3 346 (3.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
137 343
Women receive the diagnosis bullous pemphigoid
5 360 (3.9 %)Died from this diagnosis.
Risk Group for the Disease bullous pemphigoid - Men and Women aged 80-84
In Men diagnosis is most often set at age 0-14, 25-95+
Less common in men the disease occurs at Age 15-24in in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features bullous pemphigoid
Absence or low individual and public risk
Bullous pemphigoid - what does this mean
Bullous pemphigoid is an autoimmune disorder in which the body's immune system mistakenly attacks healthy tissue in the skin, causing large, fluid-filled blisters to form. it is caused by the production of antibodies that attack and damage the layers of the skin, leading to inflammation and blistering.
What happens during the disease - bullous pemphigoid
Bullous pemphigoid is an autoimmune disorder in which the body's immune system mistakenly attacks the skin's connective tissue, leading to blisters and lesions. this occurs when antibodies mistakenly attack the proteins in the top layer of the skin, which leads to the release of certain chemicals that cause inflammation and the formation of fluid-filled blisters.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the skin
- Skin biopsy
- Blood tests to measure autoantibodies
- Immunofluorescence studies
- Ultrasound imaging
- CT scan
- MRI scan
- Patch testing
- Skin scrapings for microscopic examination
Treatment and Medical Assistance
Main Goal: To reduce the severity of the skin lesions and improve the patient's quality of life.
- Prescribe topical steroids to reduce inflammation and itching
- Prescribe oral corticosteroids to reduce inflammation
- Prescribe oral immunosuppressants to reduce inflammation
- Prescribe topical immunomodulators to reduce inflammation
- Prescribe topical antibiotics to reduce bacterial infections
- Prescribe oral antihistamines to reduce itching
- Prescribe topical anti-itch medications to reduce itching
- Prescribe phototherapy to reduce inflammation
- Prescribe oral antiviral medications to reduce viral infections
- Prescribe topical antifungal medications to reduce fungal infections
- Prescribe topical emollients to reduce dryness and irritation
- Prescribe systemic antibiotics to reduce bacterial infections
- Prescribe topical calcineurin inhibitors to reduce inflammation
- Prescribe systemic antifungal medications to reduce fungal infections
- Prescribe systemic antiviral medications to reduce viral infections
- Prescribe topical anti-inflammatory medications to reduce inflammation
- Prescribe topical anti-pruritic medications to reduce itching
- Prescribe topical corticosteroids to reduce inflammation
22 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Bullous pemphigoid - Prevention
Bullous pemphigoid can be prevented by avoiding triggers such as certain medications, skin irritants, and infections. it is important to practice good hygiene, maintain a healthy diet, and get regular exercise to help the immune system fight off potential triggers. additionally, it is important to follow any treatment plan prescribed by a doctor to help reduce the risk of developing bullous pemphigoid.